Achieving a new
approach to treatment
using VR

Under specialist supervision,
we are developing VRDTx based on theories of psychotherapy.

CONTACT
VRDTx紹介
VRDTx紹介 VRDTx紹介 VRDTx紹介
MISSION

MISSION

Developing therapeutic VR utilizing our experiences in disability welfare support

We developed social skill training VR program “emou” for those with developmental disabilities, which has already been introduced to more than 100 facilities across the nation.
We will develop VRDTx (therapeutic VR) utilizing the expertise and experience gained in the course of developing emou.

MISSION
VISION
VISION VISION VISION

VISION

Delivering richer life
through VR digital therapeutics
addressing unmet medical needs

To date, we have been developing training services using VR for people with developmental disabilities. Facing various challenges in doing so, we learned about the difficulties of welfare and medical care.
We will develop new digital therapeutics, firmly based on medical evidence, to create a world in which as many people as possible can receive appropriate treatment and lead richer lives.

治療へのアクセスが限定的

Limited access to treatment

Geographical factors or medical conditions make it impossible to visit specialized therapeutic institutions. Also, many patients find it hard to receive treatment regularly due to work, childcare, or school attendance.

精神療法の実施には医師の負担が大きい

Psychotherapists suffer from heavy workloads

Psychotherapy takes a lot of time. There is no proper environment for optimal treatment and counseling within a limited time frame.

TEAM

We conduct R&D with experts in each field,
working toward achieving therapeutic VR

To date, we have been developing training services using VR for people with developmental disabilities. Facing various challenges in doing so, we learned about the difficulties of welfare and medical care.
We will develop new digital therapeutics, firmly based on medical evidence, to create a world in which as many people as possible can receive appropriate treatment and lead richer lives.

蟹江 絢子

Senior Medical Supervisor

Ayako Kanie, MD PhD

Graduated from Faculty of Medicine, University of Tsukuba. While practicing as a psychotherapist at the National Center of Neurology and Psychiatry, she was involved in research and clinical use of CBT for psychiatric disorders such as depression, anxiety, obsessive-compulsive disorder, schizophrenia, and developmental neuropathy, as well as perinatal mental health. Involved in training program.
Graduated from the doctoral course in cognitive behavioral medicine at Tokyo Medical and Dental University.
Since 2014, as a supervisor of the cognitive behavioral therapy training program of the Ministry of Health, Labor and Welfare, she has been involved in practical training in CBT for medical professionals.
Started working with Jolly Good in 2021, sharing the same vision with Kensuke Joji.

Published work: Cognitive Behavioral Therapy Refined under Supervision

Certified psychiatrist, certified psychiatrist of the Japanese Society of Psychiatry and Neurology, certified psychiatrist of the Japanese Society of General Hospital Psychiatry, Ministry of Health, Labor and Welfare cognitive behavioral therapy training program supervisor, licensed mental health physician, certified occupational physician, clinical psychologist, certified psychologist

PRODUCT CONCEPT

Access to optimal psychotherapy for all patients

社会的場面のリアルな体験で

Changing behavior and social
participation through realistic
social experiences

We aim to create a future enabling anyone to alter their behavior and play a part in society, by experiencing various scenes such as dialogues with work superiors or acquaintances, scenes of anxiety, and pleasant scenes of daily life.

専門医監修コンテンツと進行マニュアルで平準化した治療の実現へ

Enabling leveled treatment with
manuals and contents
supervised by specialists

We aim to standardize treatment by using VRDTx to supplement steps required for cognitive and behavior change, such as the explanations in advance or recall of a certain situation.

治療への新たなアクセスとアプローチの実現へ

Striving to achieve new access
and approaches to treatment

This greatly reduces the geographical and time-related barriers to patient treatment and helps promote better health.

DEVELOPMENT PIPELINE

Diseases addressed by therapeutic VR

Depression Social Anxiety Disorder Autism Spectrum Disorder Schizophrenia Dementia Chronic Pain

CONTACT

Please fill out this form and we will
contact you directly.